Literature DB >> 11822958

Measurement of intraoperative parathyroid hormone predicts long-term operative success.

Johan Westerdahl1, Pia Lindblom, Anders Bergenfelz.   

Abstract

HYPOTHESIS: A decrease in the intraoperative parathyroid hormone (PTH) level predicts long-term operative success.
DESIGN: A case series of consecutive patients undergoing parathyroidectomy with intraoperative PTH measurement.
SETTING: A university hospital. PATIENTS AND INTERVENTION: One hundred two patients with sporadic primary hyperparathyroidism underwent parathyroidectomy according to the principles of unilateral exploration with intraoperative PTH measurement. MAIN OUTCOME MEASURES: Longitudinal effects on levels of serum calcium and PTH.
RESULTS: In 94 of 98 patients who underwent primary exploration because of a solitary adenoma, intraoperative PTH decreased at least 60% 15 minutes after gland excision. The 4 cases in which PTH fell to less than 60% were classified as false negatives. Patients examined for multiglandular disease (n = 4) were correctly predicted not to have an adenoma. Twenty-two patients (22%) were unavailable for 5-year follow-up. These patients were followed up for 2 months to 48 months (median, 24 months), and none developed recurrent primary hyperparathyroidism. Of the remaining 80 patients (78%), all but 1 patient had normal or slightly decreased serum calcium levels (mean +/- SD, 9.24 +/- 0.4 mg/dL [2.31 +/- 0.10 mmol/L]) at 5-year follow-up. One patient with hypercalcemia (10.6 mg/dL [2.65 mmol/L]) was interpreted to have developed renal failure with secondary hyperparathyroidism. Thirty-four patients had elevated serum PTH levels at least once during the postoperative study period, with normal or slightly decreased calcium concentrations. The prediction of late postoperative normocalcemia by means of intraoperative PTH measurement had an overall accuracy of 95%.
CONCLUSIONS: The measurement of intraoperative PTH during surgery for primary hyperparathyroidism accurately differentiates between single- and multiple-gland disease and ensures good long-term results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822958     DOI: 10.1001/archsurg.137.2.186

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  18 in total

1.  Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidism as an indicator of complete parathyroid removal.

Authors:  Miguel Echenique Elizondo; Francisco Javier Díaz-Aguirregoitia; José Antonio Amondarain; Fernando Vidaur
Journal:  World J Surg       Date:  2005-11       Impact factor: 3.352

2.  Preoperative ¹¹C-methionine PET/CT enables focused parathyroidectomy in MIBI-SPECT negative parathyroid adenoma.

Authors:  Christina Lenschow; Peter Gassmann; Christian Wenning; Norbert Senninger; Mario Colombo-Benkmann
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

Review 3.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

4.  Surgical treatment of patients with mildly elevated parathormone and calcium levels.

Authors:  Punam P Parikh; Bassan J Allan; John I Lew
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

5.  Intraoperative calcium monitoring is insufficient to predict the surgical success of parathyroidectomy for primary hyperparathyroidism.

Authors:  Peter Gassmann; Norbert Senninger; Mario Colombo-Benkmann
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

6.  Rapid intraoperative parathyroid hormone assay--more than just a comfort measure.

Authors:  F Hanif; J C Coffey; L Romics; K O'Sullivan; F Aftab; H P Redmond
Journal:  World J Surg       Date:  2006-02       Impact factor: 3.352

7.  Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone.

Authors:  Johan Westerdahl; Anders Bergenfelz
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

8.  Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach.

Authors:  Antonio Sitges-Serra; Prieto Rosa; Mónica Valero; Estela Membrilla; Joan J Sancho
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

9.  Minimally invasive endoscopic-assisted parathyroidectomy for primary hyperparathyroidism.

Authors:  C-Y Lo; W F Chan; J M Luk
Journal:  Surg Endosc       Date:  2003-10-28       Impact factor: 4.584

10.  Effect on bone density of postoperative calcium and vitamin-D supplementation in patients with primary hyperparathyroidism: A retrospective study.

Authors:  Erik Nordenström; Johan Westerdahl; Anders Bergenfelz
Journal:  Langenbecks Arch Surg       Date:  2008-06-11       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.